Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
HIV Medicine|March 19, 2010
No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trialA Calmy, M Bloch, H Wand, et al.
HIV Medicine|November 19, 2011
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patientsA Calmy, M Bel, A Nguyen, et al.
HIV Medicine|April 16, 2008
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort StudyM Wolbers, H C Bucher, H Furrer, et al.
Journal of Internal Medicine|February 20, 2007
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapyJ A C Sterne, M May, H C Bucher, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2006
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapyS Bertschy, M Opravil, M Cavassini, et al.
HIV Medicine|September 11, 2015
Safety of zidovudine dose reduction in treatment-naïve HIV infected patients. A randomized controlled study (MiniZID)M Rougemont, P Nchotu Ngang, B Stoll, et al.
International Journal of STD & AIDS|July 4, 2017
A prospective multicentre study of healthcare provider preference in rapid HIV testing kits: Determine versus INSTIN Amyai, Kea Darling, V D'Acremont, et al.
HIV Medicine|August 16, 2014
Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort StudyR Weber, M Huber, M Battegay, et al.
HIV Medicine|January 26, 2008
Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006A Nguyen, A Calmy, V Schiffer, et al.
HIV Medicine|September 18, 2008
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort StudyC Bellini, O Keiser, J-P Chave, et al.
Pageof 11